Dominik Ruettinger

Dominik Ruettinger is an accomplished professional with a focus on translational research in oncology and tumor immunology.

He pursued his education at prestigious institutions including Oregon Health & Science University, Stanford University Graduate School of Business, and Ludwig-Maximilians-Universität München where he completed his MD and PhD.

Dominik Ruettinger has held key roles at Roche, such as Global Head Early Clinical Development Oncology and former Head of Early Clinical Development and Translational Medicine Oncology.

He has also served as an Associate Professor at Ludwig-Maximilians Universität München and held various positions at Roche including Group Head of Translational Medicine Oncology and Senior Translational Medicine Leader.

Prior to his roles at Roche, Dominik Ruettinger gained experience as a Senior Medical Director at Micromet AG and as a Postdoctoral Fellow at Providence Cancer Center in Portland, OR.

His expertise encompasses a strong background in academic research and clinical development within the oncology and tumor immunology fields.